91 – 99 of 99
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Disease models of chronic inflammatory airway disease: applications and requirements for clinical trials.
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients
(
- Contribution to journal › Article
-
Mark
Launching the BIOSPIT initiative: Harmonizing sputum outcomes in multicenter trials
(
- Contribution to journal › Letter
-
Mark
Patient knowledge, perceptions, expectations and satisfaction on allergen-specific immunotherapy: A survey
(
- Contribution to journal › Article
-
Mark
Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials.
(
- Contribution to journal › Article
-
Mark
The 5-lipoxygenase-activating protein inhibitor, GSK2190915, attenuates the early and late responses to inhaled allergen in mild asthma
(
- Contribution to journal › Article
-
Mark
Which Biomarkers Are Effective for Identifying Th2-Driven Inflammation in Asthma?
(
- Contribution to journal › Scientific review
-
Mark
Inhaled allergen bronchoprovocation tests.
(
- Contribution to journal › Article
- 2012
-
Mark
Clinical aspects of using exhaled NO in asthma diagnosis and management
(
- Contribution to journal › Scientific review